相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cholecalciferol (Vitamin D3) Therapy and Vitamin D Insufficiency in Patients with Chronic Kidney Disease: A Randomized Controlled Pilot Study
Prakash Chandra et al.
Endocrine Practice (2013)
KHA-CARI Guideline: Early chronic kidney disease: Detection, prevention and management
David W. Johnson et al.
NEPHROLOGY (2013)
High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial
Jessica A. Alvarez et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2012)
Management of Hyperglycemia, Dyslipidemia, and Albuminuria in Patients With Diabetes and CKD: A Systematic Review for a KDOQI Clinical Practice Guideline
Yelena Slinin et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Cholecalciferol Supplementation in Chronic Kidney Disease: Restoration of Vitamin D Status and Impact on Parathyroid Hormone
Miriam G. Garcia-Lopes et al.
ANNALS OF NUTRITION AND METABOLISM (2012)
Ergocalciferol Supplementation in Children with CKD Delays the Onset of Secondary Hyperparathyroidism: A Randomized Trial
Rukshana Shroff et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D
Peter Marckmann et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Vitamin D supplementation in pre-dialysis chronic kidney disease A systematic review
Jessica A. Alvarez et al.
DERMATO-ENDOCRINOLOGY (2012)
Vitamin D Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Observational Studies and Randomized Controlled Trials
Praveen Kandula et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
Michael F. Holick et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
A. Catharine Ross et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Vitamin D Deficiency, Inflammation, and Albuminuria in Chronic Kidney Disease: Complex Interactions
Tamara Isakova et al.
JOURNAL OF RENAL NUTRITION (2011)
Changes in Albuminuria Predict Mortality and Morbidity in Patients with Vascular Disease
Roland E. Schmieder et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Short-term effects of vitamin D receptor activation on serum creatinine, creatinine generation, and glomerular filtration
Matthew R. Weir
KIDNEY INTERNATIONAL (2011)
Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition
Min Jeong Kim et al.
KIDNEY INTERNATIONAL (2011)
Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts
Ron T. Gansevoort et al.
KIDNEY INTERNATIONAL (2011)
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report
Andrew S. Levey et al.
KIDNEY INTERNATIONAL (2011)
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts
Brad C. Astor et al.
KIDNEY INTERNATIONAL (2011)
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts
Marije van der Velde et al.
KIDNEY INTERNATIONAL (2011)
A Randomized Trial of Cholecalciferol versus Doxercalciferol for Lowering Parathyroid Hormone in Chronic Kidney Disease
Sharon M. Moe et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Vitamins K and D Status in Stages 3-5 Chronic Kidney Disease
Rachel M. Holden et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Relation Between Kidney Function, Proteinuria, and Adverse Outcomes
Brenda R. Hemmelgarn et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial
Dick de Zeeuw et al.
LANCET (2010)
Vitamin D insufficiency and effect of cholecalciferol in children with chronic kidney disease
Pankaj Hari et al.
PEDIATRIC NEPHROLOGY (2010)
Oral Paricalcitol in the Treatment of Patients With CKD and Proteinuria: A Randomized Trial
Steven Fishbane et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Vitamin D, Proteinuria, Diabetic Nephropathy, and Progression of CKD
Rajiv Agarwal
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
25-Hydroxyvitamin D Levels, Race, and the Progression of Kidney Disease
Michal L. Melamed et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Chronic kidney disease, hypovitaminosis D, and mortality in the United States
Rajnish Mehrotra et al.
KIDNEY INTERNATIONAL (2009)
Vitamin D levels and patient outcome in chronic kidney disease
Pietro Ravani et al.
KIDNEY INTERNATIONAL (2009)
25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients
Patricia Joao Matias et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Intracellular calcium homeostasis in patients with early stages of chronic kidney disease: effects of vitamin D3 supplementation
Ingrid Lajdova et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Hypovitaminosis D in chronic kidney disease
Rajnish Mehrotra et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Vitamin D and kidney disease
Wisam Al-Badr et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Paricalcitol reduces albuminuria and inflammation in chronic kidney disease - A randomized double-blind pilot trial
Pooneh Alborzi et al.
HYPERTENSION (2008)
Effects of Long-Term Cholecalciferol Supplementation on Mineral Metabolism and Calciotropic Hormones in Chronic Kidney Disease
Adrian Oksa et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2008)
Aliskiren combined with losartan in type 2 diabetes and nephropathy
Hans-Henrik Parving et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effect of depot oral cholecalciferol treatment on secondary hyperparathyroidism in stage 3 and stage 4 chronic kidney diseases patients
Ekrem Dogan et al.
RENAL FAILURE (2008)
25-hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III)
Ian H. de Boer et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease
A. Levin et al.
KIDNEY INTERNATIONAL (2007)
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2006)
Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD
D Coyne et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Antiproteinuric effect of oral paricalcitol in chronic kidney disease
R Agarwal et al.
KIDNEY INTERNATIONAL (2005)
Prevalence of calcidiol deficiency in CKD: A cross-sectional study across latitudes in the united states
RE LaClair et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy
D de Zeeuw et al.
CIRCULATION (2004)
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL
D de Zeeuw et al.
KIDNEY INTERNATIONAL (2004)
Vitamin D insufficiency and deficiency in chronic kidney disease - A single center observational study
EA Gonzalez et al.
AMERICAN JOURNAL OF NEPHROLOGY (2004)
Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III
AC Looker et al.
BONE (2002)
Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease
J Blacher et al.
HYPERTENSION (2001)
分享论文
